Galloway, J. A., et al., "Factors influencing the Absorption, Serum Insulin Concentration, and Blood Glucose Responses After Injections of Regular Insulin and Various Insulin Mixtures", Diabetes Care (1981) 4(3):366-376. |
Monkhouse, D.C., et al., "The Effect of EDTA on the Resistance of Pseudomonas Aeruginosa to Benzalkonium Chloride", Aust. J. Pharm. (1967) 48(570):S70-S75. |
Moses, A. C., "Routes of Administration: Nasal", Proceedings of Land O'Lake (1986) 86, Merrimac, WI, Lecture Note, pp. 1 10. |
Mygind, N., et al, "Aerosol Distribution in the Nose", Rhinology (1978) vol. XVI, pp. 79-88. |
Bito, L. Z., et al., "Transport of Prostaglandins Across the Blood-Brian and Blood Aqueous Barriers and the Physiological Significance of these Absorptive Transport Processes", Exp. Eye Research Suppl. (1977) pp. 229-243. |
McClure, D. A., "The Effect of a Pro-Drug of Epinephrine (Dipivalyl Epinephrine) in Glaucoma--General Pharmacology, Toxicology, and Clinical Experience", in Pro-Drugs as Novel Drug Delivery Systems, ACS Symposium Series No. 14, Higuchi, T., et al., editors (published by American Chemical Society, Washington, D.C., 1975), pp.; 224-235. |
Lee, V. H. L., et al., "Metabolic and Permeation Barriers to the Ocular Absorption of Topically Applied Enkephalins in Albino Rabbits", J. Ocular Pharmacol. (1986) 2(4):345-352. |
Christie, C. D., et al., "Insulin Absorption by the Conjunctival Membranes in Rabbits", J. Clin. Invest. (1931) 10:787-793. |
Ueno, N., et al., "Ocular Pharmacology of Drug Release Devices", in Controlled Drug Delivery, Vol II, Clinical Applications, Bruck, S. D., editor, (published by CRC Press, Inc., Florida, 1983), Chapter 4, pp. 89-109. |
Chiou, G. C. Y., et al., "Treatment of Hypoglycemia with Glucagon Eye Drops", J. Ocular Pharmacol. (1988) 4(2):179-186. |
Chiou, G. C. Y., et al., "Systemic Delivery of Enkephalin Peptide Through Eyes", Life Sciences (1988) 43(6):509-514. |
Chiou, G. C. Y., et al., "Reduction of Blood Glucose Concentration with Insulin Eye Drops", Diabetes Care (1988) 11(9):750-751. |
Chiou, G. C. Y., et al., "Systemic Delivery of Polypeptides with Molecular Weights of Between 300 and 3500 Through the Eyes", Journal of Ocular Pharmacology (1988) 4(2):165-177. |
Chiou, G. C. Y., et al., "Systemic Delivery of Insulin Through Eyes to Lower the Glucose Concentration", J. Ocular Pharmacol. (1989) 5(1):81-91. |
Saettone, M. F., et al., "Vehicle Effects in Opthalmic Bioavailablity: An Evaluation of Polymeric Inserts Containing Pilocarpine", J. Pharm. Pharamcol. (1984) 36:229-234. |
Aungst, B. J., et al., "Site Dependences of Absorption-Promoting Actions of Laureth 9, Na Salicylate, Na.sub.2 EDTA, and Aprotinin on Rectal, Nasal, and Buccal Insulin Delivery", Pharmaceutical Research (1988) 5(5):305-308. |
Lee Pharm. Technology (Apr. 1987) pp. 28-38. |
Lee Pharmacy International (Jun. 1985) pp. 135-138. |
Hirai et al Int'l Journal of Pharmaceutics 9 (1981) 173-184. |